The impact of psoriasis on pregnancy outcomes

Journal of Investigative Dermatology

Volumn 132, Issue 1, 2012, Pages 85-91

  Lima, Xinaida T ^a,b   Janakiraman, Vanitha ^a   Hughes, Michael D ^b   Kimball, Alexandra B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; ECLAMPSIA; FEMALE; GESTATION PERIOD; HIGH RISK PATIENT; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION;

EID: 84856113956     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.271     Document Type: Article

References (21)

1. Amarilyo G, Oren A, Mimouni FB et al. (2011) Increased cord serum inflammatory markers in small-for-gestational-age neonates. J Perinatol 31:30-2
2. Bandoli G, Johnson DL, Jones KL et al. (2010) Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis. Br J Dermatol 163:334-9
3. Bastek JA, Brown AG, Anton L et al. (2011) Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth. J Matern Fetal Neonatal Med 24:600-5
4. Ben-David G, Sheiner E, Hallak M et al. (2008) Pregnancy outcome in women with psoriasis. J Reprod Med 53:183-7 (Pubitemid 351498127)
5. Center for Disease Control and Prevention (2008) (http://www.cdc.gov/ nchs/data/nvsr/nvsr58/nvsr58-16-tables.pdf). Accessed 2 January 2011
6. Cornish J, Tan E, Teare J et al. (2007) A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56:830-7 (Pubitemid 46854200)
7. Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450-6 (Pubitemid 15016489)
8. Horn EJ, Chambers CD, Menter A et al. (2009) Pregnancy outcomes in psoriasis: why do we know so little? J Am Acad Dermatol 61:e5-8
9. Icen M, Crowson CS, McEvoy MT et al. (2008) Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol 59:981-5
10. Kagami S, Rizzo HL, Lee JJ et al. (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130:1373-83
11. Koo J (1996) Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 14:485-96 (Pubitemid 26249398)
12. Lin HC, Chen SF, Chen YH (2010) Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide populationbased study. Ann Rheum Dis 69:715-7
13. Mahadevan U, Sandborn WJ, Li DK et al. (2007) Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 133:1106-12 (Pubitemid 47494456)
14. Norgaard M, Larsson H, Pedersen L et al. (2010) Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med 268:329-37
15. Rocha-Pereira P, Santos-Silva A, Rebelo I et al. (2004) The inflammatory response in mild and in severe psoriasis. Br J Dermatol 150:917-28 (Pubitemid 38903524)
16. Seeger JD, Lanza LL, West WA et al. (2007) Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology 214:32-9 (Pubitemid 46032998)
17. Slattery MM, Morrison JJ (2002) Preterm delivery. Lancet 360:1489-97 (Pubitemid 35356329)
18. Sorokin Y, Romero R, Mele L et al. (2010) Maternal serum interleukin-6, Creactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birtho32 weeks and adverse neonatal outcomes. Am J Perinatol 27:631-40
19. Stephens BE, Vohr BR (2009) Neurodevelopmental outcome of the premature infant. Pediatr Clin North Am 56:631-46, Table of contents
20. Stoinska B, Gadzinowski J (2011) Neurological and developmental disabilities in ELBW and VLBW: follow-up at 2 years of age. J Perinatol 31:137-42
21. Strober B, Teller C, Yamauchi P et al. (2008) Effects of etanercept on Creactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol 159:322-30 (Pubitemid 352009830)